阿奇霉素对支气管哮喘患者肺功能及血清结缔组织生长因子的影响

中国临床药理学与治疗学 ›› 2013, Vol. 18 ›› Issue (2): 194-197.

阿奇霉素对支气管哮喘患者肺功能及血清结缔组织生长因子的影响

郑美梅, 王方剑, 岳铁刚, 董丽妍, 段成城

广州医学院附属深圳沙井医院呼吸内科,深圳518104,广东

收稿日期:2012-09-18 修回日期:2012-09-18 发布日期:2013-02-28
作者简介:郑美梅,女,硕士研究生,副主任医师,研究方向:支气管哮喘的发病机制及药物治疗。 Tel: 13928461765 E-mail: gdpczhengmeimei@163.com

Effects of azithromycin on lung function and serum CTGF of asthma patients

ZHENG Mei-mei, WANG Fang-jian, YUE Tie-gang, DONG Li-yan, DUAN Cheng-cheng

Department of Respiratory ,Shenzhen Shajing Hospital Affiliated to Guangzhou Medical University, Shenzhen 518104,Guangdong,China

Received:2012-09-18 Revised:2012-09-18 Published:2013-02-28

摘要/Abstract

摘要： 目的: 观察阿奇霉素治疗支气管哮喘的临床疗效,及其对肺功能、血清结缔组织生长因子(Connective tissue growth factor,CTGF)的影响。方法: 48例哮喘患者随机分入常规治疗组(A组),阿奇霉素治疗组(B组);两组均吸入布地奈德,B组加服阿奇霉素,18名健康体检者做对照组(C组);ELISA法检测受试者血清中CTGF水平。评估治疗前后,各组患者哮喘控制测试评分、肺功能、血清CTGF的变化。结果: 治疗8周后,A、B两组患者的哮喘控制测试评分、肺功能指标均较治疗前有明显改善,血清中CTGF浓度亦明显下降,差异有统计学意义(P均<0.05);治疗8周后,B组哮喘控制测试评分、肺功能指标均明显高于A组,但血清CTGF浓度明显低于A组,差异有统计学意义(P均<0.05)。结论: 阿奇霉素可能通过抑制CTGF的表达,抑制气道重塑,改善肺功能,控制哮喘。

关键词: 阿奇霉素, 支气管哮喘, 肺功能, 结缔组织生长因子, 气道重塑

Abstract: AIM: To observe the clinical efficacy of azithromycin on bronchial asthma, and the effects on lung function, serum connective tissue growth factor (CTGF). METHODS: 48 cases of asthma were randomly divided into conventional treatment group (group A), azithromycin in treatment group (group B). Two groups were inhaled budesonide, group B was given azithromycin additional, 18 healthy people were distributed to control group (group C).The level of serum CTGF was detected by enzyme-linked immunosorbent assay (ELISA).The changes of asthma control test(ACT) scores,lung function, serum CTGF were evaluated in each group patients before and after treatment.RESULTS: After 8 weeks treatment, the levels of ACT scores, lung function were significantly improved than before treatment, but the serum CTGF concentrations were decreased in group A and B(all P<0.05). After 8 weeks treatment,compared with group A,the levels of ACT scores,lung function were significantly increased in group B, but the CTGF serum concentration was decreased(all P<0.05). CONCLUSION: Azithromycin can inhibit airway remodeling, improve lung function and control asthma,the reason may be related to inhibiting the expression of CTGF.

Key words: Azithromycin, Asthma, Lung function, Connective tissue growth factor, Airway remodeling

中图分类号:

R562

郑美梅, 王方剑, 岳铁刚, 董丽妍, 段成城. 阿奇霉素对支气管哮喘患者肺功能及血清结缔组织生长因子的影响[J]. 中国临床药理学与治疗学, 2013, 18(2): 194-197.

ZHENG Mei-mei, WANG Fang-jian, YUE Tie-gang, DONG Li-yan, DUAN Cheng-cheng. Effects of azithromycin on lung function and serum CTGF of asthma patients[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(2): 194-197.

参考文献

[1] Holgate ST, Peters-Golden M, Jpanettieri RA, et al.Roles of cysteinyl leukotrienes in airway inflammation,smooth muscle function, and remodeling[J]. J Allergy Clin Immunol, 2003, 111(Suppl 1) :S18-S34.
[2] PanL H, Yamauchi K, Uzuki M, et al. Type Ⅱalveolar epithelial cells And interstitial fibroblasts express connective tissue growthfactor in IPF[J].Eur Respir J, 2001,17(6) :1220-1227.
[3] Piacentini GL, Peroni DG,Bodini A, et al.Azithromycin reduces bron-chial hyperresponsiveness and neutrophilic airway inflammation in asthmatic children:A preliminary report[J]. Allergy Asthma Proc,2007,28(2):194-198.
[4] Rottier BL,Duiverman EJ.Anti-inflammatory drug thempy in asthma[J].Paediatr Reapir Rev,2009,10(4):214-219.
[5] 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南[J].中华结核和呼吸杂志,2008,31(3):177-189.
[6] Elias JA.Airway remodeling in asthma:Unanswered questions[J].Am J Respir Crit Care Med,2000,161(3 Pt 2):S168-S171.
[7] Beckett PA, Howarth PH.RK. Pharmacotherapy and airway remodeling in asthma[J]? Thorax,2003,58(2):163-174.
[8] Chambers RC.Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention[J]?Br J Pharmacol,2008,153(S1): S367-S378.
[9] Xie S, Sukkar MB, Issa R, et al.Regulation of TGF-b1-induced connective tissue growth factor (CTGF) expression in airway smoth muscle cells[J].AmJ Physiol Lung Cell Mol Physiol,2005,288(1):L68-L76.
[10] Nishiumi S,Yoshida K,Ashida H,et al.Curcumin suppresses the transformation of an aryl hydrocarbon receptor through its phosphorylation[J].Arch Biochem Biophys,2007,466(2):267-273.
[11] 赵锐,曹丽萍,王艳.支气管哮喘患者血清CTGF 表达及其意义[J].中国医药指南,2009,7(12):183-184.
[12] 尹娟,戴元荣,徐慧,等.阿奇霉素对哮喘大鼠气道平滑肌细胞生长的影响[J].浙江医学,2010,32(5):685-697.
[13] 郑美梅,王方剑,江勇,等.结缔组织生长因子在哮喘小鼠肺组织中的表达及阿奇霉素的干预作用[J].中国基层医药,2011,18(12):1593-1595.

[1]	李静, 马丽娟, 袁圆, 王捷, 郁长治, 赵军. 吸入性糖皮质激素布地奈德相关基因多态性与哮喘疗效的关系[J]. 中国临床药理学与治疗学, 2021, 26(11): 1250-1258.
[2]	张俊秀, 沈媛媛, 杨解人, 郑书国, 郝伟. 联用芝麻素和维生素E抑制PI3K/AKT信号通路改善自发性高血压大鼠的左室纤维化[J]. 中国临床药理学与治疗学, 2020, 25(11): 1214-1222.
[3]	张文喜，刘东红，赵蓓，赵佳佳，蔡俏，高未，蔡奔奔. 阿奇霉素联合甲强龙治疗支原体肺炎肺实变患儿的随机对照临床试验[J]. 中国临床药理学与治疗学, 2018, 23(9): 1052-1055.
[4]	韩超，杨柳，张秋玲，潘竞锵，徐俊. 黄芩苷对哮喘大鼠气道重塑作用的实验研究[J]. 中国临床药理学与治疗学, 2017, 22(7): 749-754.
[5]	张佩红，陈啸洪，陈冰蓉，李华浚. 哮喘儿童血清细胞因子水平及布拉氏酵母菌干预的研究[J]. 中国临床药理学与治疗学, 2017, 22(3): 332-336.
[6]	李娜，刘桢宇，胡文，陈春林. 氨曲南联用阿奇霉素对产膜铜绿假单胞菌作用的实验研究[J]. 中国临床药理学与治疗学, 2017, 22(12): 1400-1405.
[7]	罗玲玲，滕承志，李晓笑，潘丹峰. 阿奇霉素联合盐酸氨溴索治疗小儿支原体肺炎合并急性支气管炎的临床研究[J]. 中国临床药理学与治疗学, 2017, 22(11): 1278-1282.
[8]	郝伟，沈媛媛，张俊秀，杨解人. 玉夏胶囊对自发性高血压大鼠心肌纤维化的影响[J]. 中国临床药理学与治疗学, 2016, 21(4): 378-383.
[9]	满振珍, 孙书芳, 郝万明, 韩伟, 唐华平. 布地奈德混悬液雾化维持治疗重度持续性哮喘疗效与安全性观察[J]. 中国临床药理学与治疗学, 2014, 19(5): 548-551.
[10]	郑小平, 南淼, 王和敏, 余献丹, 郑阿迈. 噻托溴铵联合沙美特罗/氟替卡松对老年支气管哮喘患者肺通气功能的改善[J]. 中国临床药理学与治疗学, 2014, 19(10): 1163-1166.
[11]	钱小英, 吴厉锋, 徐滨. 阿奇霉素对慢性阻塞性肺疾病急性加重患者的免疫调节作用研究[J]. 中国临床药理学与治疗学, 2013, 18(11): 1288-1290.
[12]	沈巨信, 秦娥, 李明晖, 孙健, 周国忠. 呼出气冷凝液白三烯、8异前列腺素、硝酸盐/亚硝酸盐检测在哮喘中的应用及孟鲁司特对炎症指标的影响[J]. 中国临床药理学与治疗学, 2012, 17(7): 802-805.
[13]	凌佼佼, 李平华. 银杏叶提取物对TGF-β₁诱导的人Tenon's囊成纤维细胞增殖的影响及其机制的初步探讨[J]. 中国临床药理学与治疗学, 2011, 16(12): 1347-1351.
[14]	郑羡河, 蒋宗明, 张昌锋, 胡双燕, 陈忠华, 陈念平. 帕瑞昔布钠预先给药对腹腔镜直肠癌根治术患者肺功能的影响[J]. 中国临床药理学与治疗学, 2011, 16(1): 71-75.
[15]	杨远, 彭小华, 林勇. CpG ODN对小鼠哮喘模型气道炎症及信号转导子和转录激活子6(STAT6)表达的影响[J]. 中国临床药理学与治疗学, 2010, 15(2): 149-153.